Evoq Remedies Limited Share Price

EVOQ Remedies Limited is an India-based pharmaceutical company. The Company is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The Company also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulfate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam, Amoxycillin Trihydrate, Ampicillin Trihydrate, Artemether, Finasteride, Imipramine, Lidocaine, and more.As of 26 May 2026, Evoq Remedies Limited share price is ₹3.30. The stock opened at ₹3.45, compared to its previous close of ₹3.45. During today's trading session, Evoq Remedies Limited share price moved in the range of ₹3.30 to ₹3.45, with an average price of ₹3.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹3.30 and a high of ₹3.45.

The market capitalization of Evoq Remedies Limited is ₹9 Crs, with a P/E ratio of 64.0 and a dividend yield of 0.00%.